Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study.
Anik R PatelJonathon R CampbellMohsen SadatsafaviFawziah MarraJames C JohnstonKirsten SmillieRichard T LesterPublished in: BMJ open (2017)
Full adherence could reduce the number of future TB cases by nearly 60%, offsetting TB-related costs and health burden. Several existing interventions are could be cost-effective to help achieve this goal.